{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T16:57:28Z","timestamp":1775753848454,"version":"3.50.1"},"reference-count":58,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:00:00Z","timestamp":1760140800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004826","name":"Natural Science Foundation of Beijing Municipality","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012427","name":"Beijing Tiantan Hospital","doi-asserted-by":"publisher","award":["7242049"],"award-info":[{"award-number":["7242049"]}],"id":[{"id":"10.13039\/501100012427","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Genomics"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.ygeno.2025.111140","type":"journal-article","created":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T20:03:47Z","timestamp":1760731427000},"page":"111140","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["TIMP1: A novel immune-related signature associated with invasiveness and inhibition of pituitary adenoma"],"prefix":"10.1016","volume":"117","author":[{"given":"Hongyu","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zenghua","family":"Mi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhijun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.ygeno.2025.111140_bb0005","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/nrendo.2014.64","article-title":"Invasive pituitary adenomas--diagnosis and emerging treatments","volume":"10","author":"Di Ieva","year":"2014","journal-title":"Nat. Rev. Endocrinol."},{"issue":"10","key":"10.1016\/j.ygeno.2025.111140_bb0010","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1007\/s12094-018-1868-6","article-title":"Recurrent non-functioning pituitary adenomas: a review on the new pathological classification, management guidelines and treatment options","volume":"20","author":"Delgado-L\u00f3pez","year":"2018","journal-title":"Clin. Transl. Oncol."},{"issue":"1","key":"10.1016\/j.ygeno.2025.111140_bb0015","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/s12957-021-02272-9","article-title":"Research advances on the immune research and prospect of immunotherapy in pituitary adenomas","volume":"19","author":"Nie","year":"2021","journal-title":"World J. Surg. Oncol."},{"issue":"2","key":"10.1016\/j.ygeno.2025.111140_bb0020","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s11154-019-09534-8","article-title":"Aggressive pituitary tumors in the young and elderly","volume":"21","author":"Tatsi","year":"2020","journal-title":"Rev. Endocr. Metab. Disord."},{"issue":"2","key":"10.1016\/j.ygeno.2025.111140_bb0025","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s11154-020-09561-w","article-title":"The journey in diagnosis and treatment, from pituitary adenoma to invasive pituitary tumors","volume":"21","author":"Fleseriu","year":"2020","journal-title":"Rev. Endocr. Metab. Disord."},{"issue":"11","key":"10.1016\/j.ygeno.2025.111140_bb0100","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.3390\/cancers11111658","article-title":"Toxicity profiles of fractionated radiotherapy, contemporary stereotactic radiosurgery, and transsphenoidal surgery in nonfunctioning pituitary macroadenomas","volume":"11","author":"Chang","year":"2019","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.ygeno.2025.111140_bb0105","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1530\/EJE-17-0796","article-title":"European society of endocrinology. European society of endocrinology clinical practice guidelines for the management of invasive pituitary tumours and carcinomas","volume":"178","author":"Raverot","year":"2018","journal-title":"Eur. J. Endocrinol."},{"issue":"11","key":"10.1016\/j.ygeno.2025.111140_bb0110","doi-asserted-by":"crossref","first-page":"R559","DOI":"10.1530\/ERC-18-0228","article-title":"invasive and malignant pituitary tumours: state-of-the-art","volume":"25","author":"Dworakowska","year":"2018","journal-title":"Endocr. Relat. Cancer"},{"issue":"2","key":"10.1016\/j.ygeno.2025.111140_bb0115","doi-asserted-by":"crossref","DOI":"10.1530\/ERC-24-0146","article-title":"Activation of the HIF1\u03b1\/TIMP1\/MT6-MMP pathway is associated with invasion in pituitary null cell adenomas","volume":"32","author":"Yu","year":"2025","journal-title":"Endocr. Relat. Cancer"},{"issue":"4","key":"10.1016\/j.ygeno.2025.111140_bb0120","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s00401-017-1769-8","article-title":"The 2017 World Health Organization classification of tumors of the pituitary gland: a summary","volume":"134","author":"Lopes","year":"2017","journal-title":"Acta Neuropathol."},{"issue":"11","key":"10.1016\/j.ygeno.2025.111140_bb0125","doi-asserted-by":"crossref","first-page":"15459","DOI":"10.18632\/aging.203103","article-title":"S100A gene family: immune-related prognostic biomarkers and therapeutic targets for low-grade glioma","volume":"13","author":"Zhang","year":"2021","journal-title":"Aging (Albany NY)"},{"issue":"7","key":"10.1016\/j.ygeno.2025.111140_bb0130","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1158\/0008-5472.CAN-21-2161","article-title":"Chaperone-mediated autophagy controls proteomic and transcriptomic pathways to maintain glioma stem cell activity","volume":"82","author":"Auzmendi-Iriarte","year":"2022","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.ygeno.2025.111140_bb0030","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3892\/ol.2014.2637","article-title":"Raf kinase inhibitor protein inhibits cholangiocarcinoma cell metastasis by downregulating matrix metalloproteinase 9 and upregulating tissue inhibitor of metalloproteinase 4 expression","volume":"9","author":"Ma","year":"2015","journal-title":"Oncol. Lett."},{"issue":"4","key":"10.1016\/j.ygeno.2025.111140_bb0035","doi-asserted-by":"crossref","first-page":"17091","DOI":"10.4238\/2015.December.16.9","article-title":"Regulating effect of MMP-9 and TIMP-1 in pituitary adenoma invasion","volume":"14","author":"Mao","year":"2015","journal-title":"Genet. Mol. Res."},{"issue":"12","key":"10.1016\/j.ygeno.2025.111140_bb0040","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.3390\/cancers11121936","article-title":"Pituitary adenomas and invasiveness from Anatomo-surgical, radiological, and histological perspectives: a systematic literature review","volume":"11","author":"Serioli","year":"2019","journal-title":"Cancers (Basel)"},{"issue":"4","key":"10.1016\/j.ygeno.2025.111140_bb0045","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1002\/path.2310","article-title":"pVHL co-ordinately regulates CXCR4\/CXCL12 and MMP2\/MMP9 expression in human clear-cell renal cell carcinoma","volume":"214","author":"Struckmann","year":"2008","journal-title":"J. Pathol."},{"issue":"8","key":"10.1016\/j.ygeno.2025.111140_bb0050","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1096\/fasebj.5.8.1850705","article-title":"Matrix metalloproteinases and their inhibitors in connective tissue remodeling","volume":"5","author":"Woessner","year":"1991","journal-title":"FASEB J."},{"issue":"1","key":"10.1016\/j.ygeno.2025.111140_bb0055","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ajpath.2011.09.008","article-title":"An alternate perspective on the roles of TIMPs and MMPs in pathology","volume":"180","author":"Moore","year":"2012","journal-title":"Am. J. Pathol."},{"issue":"1","key":"10.1016\/j.ygeno.2025.111140_bb0060","first-page":"1","article-title":"Expressions of matrix Metalloproteinases-9 and tissue inhibitor of Metalloproteinase-1 in pituitary adenomas and their relationships with prognosis","volume":"34","author":"Guo","year":"2019","journal-title":"Cancer Biother. Radiopharm."},{"issue":"3","key":"10.1016\/j.ygeno.2025.111140_bb0070","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s12022-015-9383-6","article-title":"Immune cell infiltrates in pituitary adenomas: more macrophages in larger adenomas and more T cells in growth hormone adenomas","volume":"26","author":"Lu","year":"2015","journal-title":"Endocr. Pathol."},{"issue":"3","key":"10.1016\/j.ygeno.2025.111140_bb0205","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1172\/JCI59643","article-title":"Macrophage plasticity and polarization: in vivo veritas","volume":"122","author":"Sica","year":"2012","journal-title":"J. Clin. Invest."},{"issue":"5","key":"10.1016\/j.ygeno.2025.111140_bb0210","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1182\/blood-2005-01-0428","article-title":"A distinct and unique transcriptional program expressed by tumor-related macrophages (defective NF-kappaB and enhanced IRF-3\/STAT1 activation)","volume":"107","author":"Biswas","year":"2006","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.ygeno.2025.111140_bb0215","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3889\/oamjms.2015.044","article-title":"Tumor-related macrophage (TAM) and angiogenesis in human colon carcinoma","volume":"3","author":"Badawi","year":"2015","journal-title":"Open Access Maced. J. Med. Sci."},{"issue":"11","key":"10.1016\/j.ygeno.2025.111140_bb0075","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1172\/JCI2881","article-title":"In vitro suppression of programmed cell death of B cells by tissue inhibitor of metalloproteinases-1","volume":"102","author":"Guedez","year":"1998","journal-title":"J. Clin. Invest."},{"issue":"10","key":"10.1016\/j.ygeno.2025.111140_bb0080","article-title":"Prognosis analysis and validation of m6A signature and tumor immune microenvironment in glioma","author":"Lin","year":"2020","journal-title":"Front. Oncol."},{"issue":"11","key":"10.1016\/j.ygeno.2025.111140_bb0085","article-title":"Seven genes related with lymphatic metastasis in thyroid cancer that is linked to tumor immune cell infiltration","author":"Wu","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ygeno.2025.111140_bb0090","article-title":"Quantitative proteomics identified a novel invasion biomarker associated with EMT in pituitary adenomas","volume":"14","author":"Zhang","year":"2023","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"9","key":"10.1016\/j.ygeno.2025.111140_bb0095","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1186\/1471-2105-9-559","article-title":"WGCNA: an R package for weighted correlation network analysis","author":"Langfelder","year":"2008","journal-title":"BMC Bioinform."},{"issue":"3","key":"10.1016\/j.ygeno.2025.111140_bb0135","doi-asserted-by":"crossref","first-page":"373","DOI":"10.4103\/0366-6999.150109","article-title":"PRDM14 promotes the migration of human non-small cell lung cancer through extracellular matrix degradation in vitro","volume":"128","author":"Bi","year":"2015","journal-title":"Chin. Med. J."},{"issue":"1","key":"10.1016\/j.ygeno.2025.111140_bb0140","doi-asserted-by":"crossref","first-page":"28","DOI":"10.4103\/0973-1482.157337","article-title":"Seesaw of matrix metalloproteinases (MMPs)","volume":"12","author":"Kapoor","year":"2016","journal-title":"J. Cancer Res. Ther."},{"issue":"1","key":"10.1016\/j.ygeno.2025.111140_bb0145","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1152\/physrev.00022.2006","article-title":"Matrix metalloproteinases in lung: multiple, multifarious, and multifaceted","volume":"87","author":"Greenlee","year":"2007","journal-title":"Physiol. Rev."},{"issue":"24","key":"10.1016\/j.ygeno.2025.111140_bb0150","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21249739","article-title":"The roles of matrix metalloproteinases and their inhibitors in human diseases","volume":"21","author":"Cabral-Pacheco","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.ygeno.2025.111140_bb0155","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1093\/neuonc\/noz189","article-title":"CCL5 of glioma-related microglia\/macrophages regulates glioma migration and invasion via calcium-dependent matrix metalloproteinase 2","volume":"22","author":"Yu-Ju","year":"2020","journal-title":"Neuro-Oncology"},{"issue":"7","key":"10.1016\/j.ygeno.2025.111140_bb0160","doi-asserted-by":"crossref","first-page":"3403","DOI":"10.3390\/ijms22073403","article-title":"Metalloproteinases in ovarian cancer","volume":"22","author":"Carey","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.ygeno.2025.111140_bb0165","doi-asserted-by":"crossref","first-page":"3619","DOI":"10.21873\/anticanres.14351","article-title":"Gene polymorphisms and circulating levels of MMP-2 and MMP-9: a review of their role in breast cancer risk","volume":"40","author":"Dofara","year":"2020","journal-title":"Anticancer Res."},{"issue":"1","key":"10.1016\/j.ygeno.2025.111140_bb0170","doi-asserted-by":"crossref","DOI":"10.1177\/1073274818789357","article-title":"Human plasma levels of vascular endothelial growth factor, matrix metalloproteinase 9, and tissue inhibitor of matrix metalloproteinase 1 and their applicability as tumor markers in diagnoses of cervical Cancer based on ROC analysis","volume":"25","author":"Zajkowska","year":"2018","journal-title":"Cancer Control"},{"issue":"6","key":"10.1016\/j.ygeno.2025.111140_bb0175","doi-asserted-by":"crossref","first-page":"4377","DOI":"10.1007\/s13277-015-3077-z","article-title":"Overexpression of SMYD3 and matrix metalloproteinase-9 are related with poor prognosis of patients with gastric cancer","volume":"36","author":"Liu","year":"2015","journal-title":"Tumour Biol."},{"issue":"7","key":"10.1016\/j.ygeno.2025.111140_bb0180","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1023\/A:1006760632766","article-title":"Expression of matrix metalloproteinases and their inhibitors in human brain tumors","volume":"17","author":"Kachra","year":"1999","journal-title":"Clin. Exp. Metastasis"},{"issue":"3","key":"10.1016\/j.ygeno.2025.111140_bb0185","doi-asserted-by":"crossref","first-page":"355","DOI":"10.4331\/wjbc.v5.i3.355","article-title":"Matrix metalloproteinases and gastrointestinal cancers: impacts of dietary antioxidants","volume":"5","author":"Verma","year":"2014","journal-title":"World J. Biol. Chem."},{"issue":"27","key":"10.1016\/j.ygeno.2025.111140_bb0190","doi-asserted-by":"crossref","first-page":"5381","DOI":"10.1038\/s41388-019-0779-5","article-title":"Tumor microenvironment defines the invasive phenotype of AIP-mutation-positive pituitary tumors","volume":"38","author":"Barry","year":"2019","journal-title":"Oncogene"},{"issue":"5","key":"10.1016\/j.ygeno.2025.111140_bb0195","doi-asserted-by":"crossref","first-page":"695","DOI":"10.3390\/jcm8050695","article-title":"Analysis of tumor angiogenesis and immune microenvironment in non-functional pituitary endocrine Tumors","volume":"8","author":"Sato","year":"2019","journal-title":"J. Clin. Med."},{"issue":"3","key":"10.1016\/j.ygeno.2025.111140_bb0200","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s11102-020-01114-3","article-title":"Immune profiling of pituitary tumors reveals variations in immune infiltration and checkpoint molecule expression","volume":"24","author":"Mei","year":"2021","journal-title":"Pituitary"},{"issue":"49","key":"10.1016\/j.ygeno.2025.111140_bb0220","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000009056","article-title":"Detection of programmed death ligand 1 protein and CD8+ lymphocyte infiltration in plurihormonal pituitary adenomas: a case report and review of the literatures","volume":"96","author":"Wang","year":"2017","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"10.1016\/j.ygeno.2025.111140_bb0225","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s11060-018-2844-2","article-title":"The expression profile of PD-L1 and CD8+ lymphocyte in pituitary adenomas indicating for immunotherapy","volume":"139","author":"Wang","year":"2018","journal-title":"J. Neuro-Oncol."},{"key":"10.1016\/j.ygeno.2025.111140_bb0230","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2020.608422","article-title":"The Progress of immunotherapy in refractory pituitary adenomas and pituitary carcinomas","volume":"11","author":"Dai","year":"2020","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"2","key":"10.1016\/j.ygeno.2025.111140_bb0235","doi-asserted-by":"crossref","first-page":"308","DOI":"10.3390\/cancers12020308","article-title":"Exploring the role of novel medical therapies for invasive pituitary Tumors: a review of the literature-\u201care we there yet?\u201d","volume":"12","author":"Lamb","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ygeno.2025.111140_bb0245","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.982026","article-title":"Harnessing the immune system by targeting immune checkpoints: providing new hope for oncotherapy","volume":"13","author":"Yu","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ygeno.2025.111140_bb0250","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1146\/annurev-pathol-042020-042741","article-title":"Immune checkpoint inhibitors for the treatment of cancer: clinical impact and mechanisms of response and resistance","volume":"16","author":"Bagchi","year":"2021","journal-title":"Annu. Rev. Pathol."},{"issue":"2","key":"10.1016\/j.ygeno.2025.111140_bb0255","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-001014","article-title":"LAG-3: from molecular functions to clinical applications","volume":"8","author":"Maruhashi","year":"2020","journal-title":"J. Immunother. Cancer"},{"issue":"17","key":"10.1016\/j.ygeno.2025.111140_bb0260","doi-asserted-by":"crossref","first-page":"7875","DOI":"10.1073\/pnas.1003345107","article-title":"Tumor-infiltrating NY-ESO-1-specific CD8+ T cells are negatively regulated by LAG-3 and PD-1 in human ovarian cancer","volume":"107","author":"Matsuzaki","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"37","key":"10.1016\/j.ygeno.2025.111140_bb0265","doi-asserted-by":"crossref","first-page":"61425","DOI":"10.18632\/oncotarget.18251","article-title":"Expression of LAG-3 defines exhaustion of intratumoral PD-1+ T cells and correlates with poor outcome in follicular lymphoma","volume":"8","author":"Yang","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.ygeno.2025.111140_bb0270","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/290854","article-title":"Prognostic significance of tissue inhibitor of metalloproteinase-1 in breast cancer","volume":"2012","author":"Dechaphunkul","year":"2012","journal-title":"Int. J. Breast Cancer"},{"issue":"28","key":"10.1016\/j.ygeno.2025.111140_bb0275","doi-asserted-by":"crossref","first-page":"3640","DOI":"10.1038\/onc.2014.300","article-title":"Tissue inhibitor of metalloproteinases-1 induces a pro-tumourigenic increase of miR-210 in lung adenocarcinoma cells and their exosomes","volume":"34","author":"Cui","year":"2015","journal-title":"Oncogene"},{"issue":"9","key":"10.1016\/j.ygeno.2025.111140_bb0280","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1038\/bjc.2014.462","article-title":"Urinary TIMP-1 and MMP-2 levels detect the presence of pancreatic malignancies","volume":"111","author":"Roy","year":"2014","journal-title":"Br. J. Cancer"},{"issue":"11","key":"10.1016\/j.ygeno.2025.111140_bb0285","doi-asserted-by":"crossref","first-page":"8277","DOI":"10.1007\/s13277-015-3564-2","article-title":"Serum markers in early-stage and locally advanced melanoma","volume":"36","author":"Lugowska","year":"2015","journal-title":"Tumour Biol."},{"issue":"4","key":"10.1016\/j.ygeno.2025.111140_bb0290","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s00018-013-1457-3","article-title":"Cytokine functions of TIMP-1","volume":"71","author":"Ries","year":"2014","journal-title":"Cell. Mol. Life Sci."},{"issue":"12","key":"10.1016\/j.ygeno.2025.111140_bb0295","doi-asserted-by":"crossref","first-page":"4244","DOI":"10.1111\/cas.15567","article-title":"TIMP1 promotes cell proliferation and invasion capability of right-sided colon cancers via the FAK\/Akt signaling pathway","volume":"113","author":"Ma","year":"2022","journal-title":"Cancer Sci."},{"issue":"12","key":"10.1016\/j.ygeno.2025.111140_bb0300","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1002\/2211-5463.13005","article-title":"IL35 predicts prognosis in gastric cancer and is related with angiogenesis by altering TIMP1, PAI1 and IGFBP1","volume":"10","author":"Li","year":"2020","journal-title":"FEBS Open Bio."}],"container-title":["Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0888754325001569?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0888754325001569?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T15:04:55Z","timestamp":1766070295000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0888754325001569"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":58,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S0888754325001569"],"URL":"https:\/\/doi.org\/10.1016\/j.ygeno.2025.111140","relation":{},"ISSN":["0888-7543"],"issn-type":[{"value":"0888-7543","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"TIMP1: A novel immune-related signature associated with invasiveness and inhibition of pituitary adenoma","name":"articletitle","label":"Article Title"},{"value":"Genomics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygeno.2025.111140","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"111140"}}